Warning letters, 483s, Recalls, Import Alerts, Audit observations
USFDA has issued a Warning letter to Glenmark Pharma’s Pithampur manufacturing facility (FEI 3008565058). The
The U.S. Food and Drug Administration (FDA) has issued a Warning Letter in June 2025
The USFDA issued a warning letter in January 2025 to Sanofi’s API facility in Framingham,
As expected FDA has taken regulatory action and issued a Warning letter to Natco, following
In May 2023 several Injectable products manufactured by Indian Contract Manufacturer Astral SteriTech Pvt. Ltd
